- E Pucci (e.pucci@fastnet.it), Neurologist,
- N Belardinelli, Neurologist,
- M Signorino, Neurologist,
- F Angeleri, Professor of neurology
- Istituto Malattie del Sistema Nervoso, Clinica Neurologica, Universitá di Ancona, Ospedale Regionale Torrette, 60020 Ancona, Italy
EDITOR—We appreciated Featherstone and Donovan's report about patients' perspectives of participation in a randomised controlled trial.1 We recently investigated the ability of 40 middle aged and elderly caregivers to understand and retain information about randomised controlled trials in patients with Alzheimer's disease.
Eighteen caregivers were men and 22 women, and their mean age was 64 (SD 6) (range 50-76). They had had …
Sign in
Personal subscribers, sign in here:
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
Ethical considerations
Published 14 February 2012
Re: Diagnosis and management of Raynaud’s phenomenon
Published 14 February 2012
Re: Raised inflammatory markers
Published 14 February 2012
Re: Physical activity for cancer survivors: meta-analysis of randomised controlled trials
Published 14 February 2012
Smokefree cars in Wales: Laws are better
Published 14 February 2012
Most responses
Does anyone understand the government’s plan for the NHS? (17 responses)
Published 17 Jan 2012
Bad medicine: medical nutrition (15 responses)
Published 18 Jan 2012
Shared decision making: really putting patients at the centre of healthcare (8 responses)
Published 27 Jan 2012
Why legislation is necessary for my health reforms (8 responses)
Published 1 Feb 2012
How much of a social media profile can doctors have? (7 responses)
Published 23 Jan 2012